FDA Inspection 794702 — Vertex Pharmaceuticals Incorporated
The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on August 2, 2012 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 2, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)